Article Information
History
- January 5, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Manuela Di Fusco1,*,
- Shailja Vaghela2,
- Mary M Moran3,
- Jay Lin4,
- Jessica E Atwell1,
- Deepa Malhotra1,
- Thomas Scassellati Sforzolini1,
- Alejandro Cane1,
- Jennifer L Nguyen1 and
- Leah J McGrath1
- 1Pfizer Inc., New York, NY USA
- 2HealthEcon Consulting, Inc., Ancaster, ON Canada
- 3Pfizer Inc., Collegeville, PA USA
- 4Novosys Health, Green Brook, NJ, USA
- ↵*Corresponding author
Manuela Di Fusco, Patient and Health Impact, Health Economics and Outcomes Research, Pfizer, Inc., New York, NY, USA, Manuela.difusco{at}pfizer.com